Literature DB >> 11829347

Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41.

J L Mankowski1, S E Queen, P M Tarwater, K J Fox, V H Perry.   

Abstract

Axonal damage represented by accumulation of beta-amyloid precursor protein (beta-APP) develops in numerous central nervous system (CNS) diseases including human immunodeficiency virus (HIV) infection. To study the underlying mechanisms of axonal damage associated with HIV CNS infection, the amount of axonal beta-APP immunostaining in the corpus callosum of 24 simian immunodeficiency virus (SIV)-infected macaques and 3 control macaques was measured by computerized image analysis. The amounts of beta-APP accumulation were then compared with time post-inoculation, extent and character of CNS inflammation, and viral load in the CNS measured by the amount of immunohistochemical staining for the viral transmembrane protein gp41. Significant increases over control values were present in 10 of 24 SIV-infected animals. SIV encephalitis was present in 9 of the 10 animals with elevated beta-APP Increases in beta-APP correlated most strongly with levels of SIV gp41 in the brain (p = 0.005), but significant associations with macrophage infiltration and microglial activation (p = 0.04) and infiltration by cytotoxic lymphocytes (p = 0.05) also were identified. These data demonstrate that beta-APP accumulation in the white matter of SIV-infected macaques develops during SIV infection in close correlation with levels of viral replication and may serve as a sensitive marker of neuronal/axonal damage mediated by viral proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829347     DOI: 10.1093/jnen/61.1.85

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  35 in total

1.  HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum.

Authors:  Jingdong Zhang; Jianuo Liu; Bryan Katafiasz; Howard Fox; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-02       Impact factor: 4.147

2.  Tat peptides inhibit neprilysin.

Authors:  Abigail Daily; Avindra Nath; Louis B Hersh
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

3.  SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation.

Authors:  Michael Weed; Robert J Adams; Robert D Hienz; Kelly A Meulendyke; Michael E Linde; Janice E Clements; Joseph L Mankowski; M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-28       Impact factor: 4.147

4.  Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.

Authors:  Magnus Gisslén; Jan Krut; Ulf Andreasson; Kaj Blennow; Paola Cinque; Bruce J Brew; Serena Spudich; Lars Hagberg; Lars Rosengren; Richard W Price; Henrik Zetterberg
Journal:  BMC Neurol       Date:  2009-12-22       Impact factor: 2.474

Review 5.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

Review 6.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

7.  Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model.

Authors:  Gigi J Ebenezer; Victoria A Laast; Brandon Dearman; Peter Hauer; Patrick M Tarwater; Robert J Adams; M Christine Zink; Justin C McArthur; Joseph L Mankowski
Journal:  J Comp Neurol       Date:  2009-05-20       Impact factor: 3.215

8.  Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus.

Authors:  Woong-Ki Kim; Sarah Corey; Gillian Chesney; Heather Knight; Sherry Klumpp; Christian Wüthrich; Norman Letvin; Igor Koralnik; Andrew Lackner; Ronald Veasey; Kenneth Williams
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

9.  Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

Authors:  Cristian L Achim; Anthony Adame; Wilmar Dumaop; Ian P Everall; Eliezer Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-17       Impact factor: 4.147

10.  HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

Authors:  Brian Giunta; Yuyan Zhou; Huayan Hou; Elona Rrapo; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.